Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study
ATO-SR-DM
1 other identifier
interventional
1,200
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Jun 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 11, 2008
CompletedFirst Posted
Study publicly available on registry
November 13, 2008
CompletedNovember 13, 2008
November 1, 2008
1.3 years
November 11, 2008
November 11, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of dilated eye examination
12-months following intervention
Secondary Outcomes (3)
Completion of glycated hemoglobin testing (HbA1c)
one-year following intervention
Completion of LDL-cholesterol testing
one year following intervention
Completion of microalbumin testing
one-year following intervention
Study Arms (2)
ATO-SR
EXPERIMENTALAutomated Telephone Outreach with Speech Recognition
Usual Care
NO INTERVENTIONUsual Care
Interventions
Automated Telephone Outreach with Speech Recognition
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
- Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)
You may not qualify if:
- No primary care clinician in the data base
- Those who had previously asked the health plan to exclude them from research or quality improvement
- Women whose claim records contained diagnoses suggesting gestational diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harvard Pilgrim Health Carelead
- American Diabetes Associationcollaborator
Study Sites (1)
Harvard Pilgrim Health Care
Boston, Massachusetts, 02215, United States
Related Publications (1)
Simon SR, Trinacty CM, Soumerai SB, Piette JD, Meigs JB, Shi P, Ensroth A, Ross-Degnan D. Improving diabetes care among patients overdue for recommended testing: a randomized controlled trial of automated telephone outreach. Diabetes Care. 2010 Jul;33(7):1452-3. doi: 10.2337/dc09-2332. Epub 2010 Mar 31.
PMID: 20357376DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven R Simon, MD
Harvard Pilgrim Health Care
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 11, 2008
First Posted
November 13, 2008
Study Start
June 1, 2006
Primary Completion
October 1, 2007
Study Completion
October 1, 2007
Last Updated
November 13, 2008
Record last verified: 2008-11